Search Results

Research indicates that E. coli toxins might be contributing to colon cancer in younger populations

Loss of SOX9 gene results in greater tumor invasion and poor outcomes in mice

In a Pooled Analysis of Data from the Two Trials, the Researchers Focused on the 1,908 Patients Who were Alive Without a Recurrence of their Cancer After 3 Years.

This device would support early detection of the second-deadliest U.S. cancer

Patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug after surgery lived significantly longer.

In Pennsylvania, about 34% of those diagnosed with colorectal cancer die from the disease.